SCHEMBL3172699

SCHEMBL3172699

CC(=O)NCCNc1cc(NC(=O)CN2CCN(c3ccccc3F)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.51
▸ TSHR P16473 5/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ ALOX15 P16050 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ KMT2A Q03164 4/20 0.48
▸ CYP1A2 P05177 3/20 0.48
▸ CYP2C9 P11712 3/20 0.48
▸ CYP2C19 P33261 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ GFER P55789 1/20 0.48
▸ LMNA P02545 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ L3MBTL1 Q9Y468 3/20 0.47
▸ GAA P10253 1/20 0.47
▸ HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3175773 0.90 GAA (0.55) ALDH1A1ALOX15SMN1; SMN2KMT2AMEN1
SCHEMBL3162425 0.88 EGFR (0.53) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1
SCHEMBL3175718 0.88 DRD4 (0.51) ALDH1A1ALOX15CYP1A2CYP3A4MAPT
SCHEMBL3175833 0.88 DRD4 (0.51) ALDH1A1TSHRMAPK1SMN1; SMN2KMT2A
SCHEMBL3162798 0.88 MEN1 (0.48) ALDH1A1MAPK1KMT2AMEN1KDM4E
SCHEMBL3161698 0.88 ALDH1A1 (0.54) ALDH1A1ALOX15SMN1; SMN2KMT2AMEN1
SCHEMBL3160939 0.87 ALDH1A1 (0.52) ALDH1A1TSHRHSD17B10ALOX15MAPK1
SCHEMBL3162900 0.86 MAPT (0.44) ALDH1A1TSHRALOX15SMN1; SMN2KMT2A
SCHEMBL3260259 0.86 ALDH1A1 (0.45) ALDH1A1TSHRALOX15SMN1; SMN2KMT2A
SCHEMBL3171920 0.86 ADORA1 (0.47) ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback